WebMabThera a été administré le premier jour de chaque cure. Un total de 321 patients (162 R-CVP, 159 CVP) a reçu le traitement et a été analysé en terme d'efficacité. Le suivi médian des patients était de 53 mois. R-CVP a conduit à un bénéfice significatif par rapport à CVP pour le critère principal, le temps jusqu'à échec du ... http://mymed.ro/mabthera-rituximab-prospect.html
Roche MabThera / Rituxan (rituximab)
Webmp: Preparare manuala beton: 50 – 80 Lei: mp: LUCRARI ADIACENTE: TIP: PRET: U.M. Sapaturi manuale : 80 – 100 Lei: mc: Montat fier beton: 1,5 – 2 Lei: kg: Montat / … WebMabThera, 1400 mg soluţie injectabilă, 1 flacon, Roche. Indicatii: MabThera 1400 mg se utilizează pentru tratamentul limfomului non-Hodgkin la pacienţii adulţi. - Acesta este o … peter the great beard token
MabThera® 100 mg/- 500 mg Konzentrat zur Herstellung einer ...
WebRituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in non-geriatric patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic … WebMabThera este primul tratament care a demonstrat imbunatatirea supravietuirii globale la pacientii cu leucemie limfocitara cronica netratatati anterior. Rezultatele actualizate arata … Web24 ian. 2024 · MabThera is a ready to use, clear to opalescent, colourless to yellowish liquid, supplied as a solution for subcutaneous injection in a colourless glass vial with a butyl rubber stopper with aluminium over seal and a pink plastic flip-off disk. Each vial contains 1400 mg/11.7 mL of rituximab. Each carton contains one vial. peter the great and louis xiv similarities